H. Sader

发表

Oxacillin- and Quinolone-Resistant Staphylococcus Aureus in Sao Paulo, Brazil: A Multicenter Molecular Epidemiology Study

Ronald N. Jones, R. Jones, R. Hollis, 1993, Infection Control & Hospital Epidemiology.

Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program.

J. Turnidge, J. Verhoef, M. Pfaller, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).

J. Verhoef, M. Pfaller, G. Doern, 1999, Diagnostic microbiology and infectious disease.

Use of macrorestriction analysis to demonstrate interhospital spread of multiresistant Acinetobacter baumannii in São Paulo, Brazil.

M. Pfaller, A. Pignatari, C. Mendes, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program.

M. Castanheira, R. Jones, A. Gales, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).

J. Verhoef, R. Jones, A. Gales, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence and Antimicrobial Susceptibility Profile of ESBL- and KPC-producing Enterobacteriaceae in the United States (2003 − 2008)

M. Castanheira, H. Sader, R. Jones, 2010 .

Antimicrobial Characterization of CEM-101: Activity Against Staphylococci, β-Haemolytic and Viridans Group Streptococci

H. Sader, R. Jones, D. Biedenbach, 2009 .

First Year Antimicrobial Surveillance Results for CEM-101, a Novel Fluoroketolide with Potent Activity Against Pathogens Associated with Community-acquired Bacterial Pneumonia

H. Sader, R. Jones, 2009 .

The use of molecular techniques in the epidemiology and control of infectious diseases.

M. Pfaller, R. Hollis, H. Sader, 1995, Clinics in laboratory medicine.

Antimicrobial Resistance among Gram-Positive Bacteria Isolated in Latin American Hospitals

H. Sader, R. Jones, G. Moet, 2009, Journal of chemotherapy.

Update on the In Vitro Activity of Daptomycin Tested against 17,193 Gram-positive Bacteria Isolated From European Medical Centers (2005-2007)

H. Sader, R. Jones, G. Moet, 2009, Journal of chemotherapy.

Decreasing Susceptibility Rates Among Acinetobacter spp. Clinical Isolates Collected Worldwide (2005-2008)

H. Sader, R. Mendes, R. Jones, 2009 .

Tigecycline Activity Tested against Carbapenem-Resistant Enterobacteriaceae from European Hospitals: Results from the SENTRY Program (2010-2013)

M. Castanheira, H. Sader, D. Farrell, 2014 .

Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?

Ronald N. Jones, F. Baquero, R. Cantón, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit.

M. Burattini, R. Jones, R. Hollis, 1993, Diagnostic microbiology and infectious disease.

In vitro activity of ampicillin-sulbactam against clinical multiresistant Acinetobacter baumannii isolates.

A. Gales, S. Sinto, C. Mendes, 1996, Journal of chemotherapy.

Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group.

M. Pfaller, G. Doern, D. Diekema, 2000, International journal of antimicrobial agents.

Eight-year (2002-2009) Summary of the Linezolid (Zyvox® Annual Appraisal of potency and Spectrum; ZAAPS) Program in European Countries

D. Farrell, R. Jones, R. Mendes, 2011, Journal of chemotherapy.

Tigecycline Activity Tested Against Commonly Isolated Skin and Skin Structure Infection (cSSSI) Pathogens: 2009 USA Surveillance Results

H. Sader, D. Farrell, R. Jones, 2010 .

Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997.

M. Pfaller, G. Doern, D. Diekema, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group.

M. Pfaller, G. Doern, R. Jones, 1999, Diagnostic microbiology and infectious disease.

Gepotidacin (GSK2140944) In Vitro Activity against Gram-Positive and Gram-Negative Bacteria

D. Farrell, R. Flamm, H. Sader, 2017, Antimicrobial Agents and Chemotherapy.

Arbekacin Tested against Well Characterized Multidrug-Resistant (MDR) Gram-negative Bacilli and Methicillin-Resistant Staphylococcus aureus (MRSA)

D. Farrell, R. Jones, H. Sader, 2014 .

Comparative Antimicrobial Potency of Meropenem Tested Against Gram-Negative Bacilli: Report from the MYSTIC Surveillance Program in the United States (2004)

P. Rhomberg, R. Jones, T. Fritsche, 2005, Journal of chemotherapy.

Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.

H. Sader, H. Sader, I. Tosin, 1999, Diagnostic microbiology and infectious disease.

Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014).

M. Pfaller, R. Jones, R. Mendes, 2017, Diagnostic microbiology and infectious disease.

Activity of Ceftaroline-Avibactam Tested Against Multidrug-Resistant Enterobacteriaceae and Methicillin-Resistant Staphylococcus aureus Collected from USA Hospitals in 2011

M. Castanheira, H. Sader, R. Flamm, 2012 .

Prevalence and Genetic Characterization of bla CTX-M Among Klebsiella pneumoniae Isolates Collected in an Intensive Care Unit in Brazil

M. Castanheira, A. Gales, M. Tognim, 2008, Journal of chemotherapy.

In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies

H. Sader, R. N. Jones, R. Jones, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs

R. Jones, H. Sader, H. Sader, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Sustained Antimicrobial Activity of Tigecycline Against Methicillin-Resistant Staphylococcus aureus (MRSA) from United States Medical Centers from 2004 Through 2008

D. Farrell, R. Jones, H. Sader, 2010, Journal of chemotherapy.

Telavancin Activity Against Gram-Positive Bacteria Isolated from Patients with Skin and Skin-Structure Infections

M. Pfaller, R. Jones, H. Sader, 2010, Journal of chemotherapy.

Update of the activity of telavancin against a global collection of Staphylococcus aureus causing bacteremia, including endocarditis (2011–2014)

M. Castanheira, H. Sader, R. Mendes, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

Antimicrobial Spectrum and Potency of Dalbavancin Tested Against Clinical Isolates from Europe and North America (2003): Initial Results from an International Surveillance Protocol

R. Jones, B. Goldstein, T. Fritsche, 2005, Journal of chemotherapy.

In Vitro Evaluation of PTK796 Activity Tested against Staphylococcus aureus, Including Hospital- and Community-Associated MRSA Strains from the USA and Europe

H. Sader, R. Jones, D. Biedenbach, 2010 .

Daptomycin In Vitro Activity Tested Against Gram-Positive Strains Collected from European and Latin American Medical Centers in 2003

T. Fritsche, H. Sader, J. Streit, 2005, Journal of chemotherapy.

Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches

D. Andes, S. Bhavnani, P. Ambrose, 2023, Antimicrobial agents and chemotherapy.

Update on Daptomycin Activity and Spectrum when Tested against Gram-positive Strains Collected in European Medical Centers (2007-2008)

M. Castanheira, H. Sader, R. Jones, 2009 .

Activity of CEM-101, a Novel Fluoroketolide, Tested Against Invasive Isolates of N. meningitidis from a Worldwide Collection

H. Sader, L. Woosley, R. Jones, 2009 .

Pulsed-field gel electrophoresis of restriction-digested genomic DNA and antimicrobial susceptibility of Xanthomonas maltophilia strains from Brazil, Switzerland and the USA.

R. Jones, R. Frei, R. Hollis, 1994, The Journal of antimicrobial chemotherapy.

Antimicrobial resistance in Brazil: comparison of results from two multicenter studies.

H. Sader, 2000, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones

H. Sader, M. Erwin, R. Jones, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Microbiological and Epidemiological Characterization of Imipenem-Resistant Pseudomonas aeruginosa Strains from a Brazilian Tertiary Hospital: Report from the SENTRY Antimicrobial Surveillance Program

R. Jones, H. Sader, R. Mendes, 2006, Journal of chemotherapy.

In Vitro Spectrum of Pexiganan Against Pathogens from Diabetic Foot Infections and with Selected Resistance Mechanisms

H. Sader, P. Rhomberg, D. Farrell, 2014 .

Antimicrobial Activity of TD-1607 Tested against Contemporary (2010-2012) Methicillin-Resistant Staphylococcus aureus (MRSA) Strains

H. Sader, P. Rhomberg, D. Farrell, 2014 .

Antimicrobial Susceptibility of Daptomycin and Comparator Agents Tested against Bloodstream Isolates of Staphylococcus aureus: Analysis of a Five-year Trend in European Medical Centres (2005-2009)

H. Sader, R. Jones, D. Biedenbach, 2010 .

Antimicrobial Characterization of CEM-101: Activity Against Enterococci, Uncommon Gram-positive Pathogens, N. gonorrhoeae and Anaerobes

H. Sader, D. Biedenbach, T. Fritsche, 2008 .

Re-evaluation of the Role of Broad-Spectrum Cephalosporins Against Staphylococci by Applying Contemporary In-Vitro Results and Pharmacokinetic- Pharmacodynamic Principles

M. Pfaller, R. Jones, S. Bhavnani, 2007, Journal of chemotherapy.

Daptomycin Activity and Spectrum when Tested against Contemporary (2009) Gram-positive Strains Collected in European Medical Centers

S. Putnam, H. Sader, R. Jones, 2010 .

Antimicrobial Activity of Solithromycin (CEM-101), a Novel Fluoroketolide, Tested Against Isolates Collected in Europe during 2010 Surveillance

H. Sader, D. Farrell, R. Jones, 2011 .

Antimicrobial Activity of a New Fluoroketolide Solithromycin (CEM-101) Tested Against Fastidious Gram-negative Community-Acquired Bacterial Pneumonia Pathogens

H. Sader, D. Farrell, R. Jones, 2010 .